Ryvu Therapeutics Sa

This study tests a new drug, MEN1703, given alone or with another drug called glofitamab, in people with aggressive B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior treatments. About 178 adults will join to see if the treatment is safe and hel…

This study tests an experimental drug called RVU120 in adults with intermediate or high-risk myelofibrosis, a type of bone marrow cancer. Participants receive RVU120 alone or combined with the standard drug ruxolitinib. The main goal is to see if the drug can shrink the spleen an…